Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

Jenkins, Abi;(BSAC Working Party on Therapeutic Drug Monitoring);Thomson, Alison H.;(BSAC Working Party on Therapeutic Drug Monitoring);Brown, Nicholas M.;(BSAC Working Party on Therapeutic Drug Monitoring);Semple, Yvonne;(BSAC Working Party on Therapeutic Drug Monitoring);Sluman, Christine;(BSAC Working Party on Therapeutic Drug Monitoring);MacGowan, Alasdair;(BSAC Working Party on Therapeutic Drug Monitoring);Lovering, Andrew M.;(BSAC Working Party on Therapeutic Drug Monitoring);Wiffen, Phil J.;(BSAC Working Party on Therapeutic Drug Monitoring);
journal of antimicrobial chemotherapy 2016 Vol. 71 pp. 2754-2759
184
abi2016journalamikacin

Abstract

Despite a comprehensive search of the literature, the authors failed to find sufficient evidence for providing guidelines on amikacin dosing and therapeutic dru

Keywords

Citation

ID: 266709
Ref Key: abi2016journalamikacin
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
266709
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet